PFWA
NTLA icon

Paces Ferry Wealth Advisors’s Intellia Therapeutics NTLA Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-200
Closed -$4K – 776
2020
Q3 		$4K Buy
+200
New +$4.17K ﹤0.01% 560

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM

Paces Ferry Wealth Advisors's NTLA Position: Q4 2020 in Review

Paces Ferry Wealth Advisors sold out of Intellia Therapeutics (NTLA) in Q4 2020, closing a stake of 200 shares — an estimated $4K sold.

Paces Ferry Wealth Advisors first reported a position in NTLA in Q3 2020 and held it in 1 quarter. The position peaked at $4K in Q3 2020. 240 funds tracked by Wall St. Rank hold NTLA as of Q4 2020.

  • Paces Ferry Wealth Advisors reported no remaining Intellia Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Paces Ferry Wealth Advisors sold 200 Intellia Therapeutics shares in Q4 2020, an estimated $4K.
  • Paces Ferry Wealth Advisors first reported a position in Intellia Therapeutics in Q3 2020 and held it in 1 quarter.
  • Paces Ferry Wealth Advisors's Intellia Therapeutics position peaked at $4K in Q3 2020.
  • 240 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2020.

Based on Paces Ferry Wealth Advisors's 13F filing for Q4 2020, filed 5 Mar 2021.